3. TABLE 1. Health Supervision for Children With Down Syndrome—Committee on Genetics*
Prenatal Infancy, 1 Month to 1 Year Early Childhood, 1 to 5 Years Late Childhood, Adolescence,
5 to 13 Years, 13 to 21 Years,
Neonatal 2 Months 4 Months 6 Months 9 Months 12 Months 15 Months 18 Months 24 Months 3 Years 4 Years Annual Annual
Diagnosis
Karyotype review† • •
Phenotype review • •
Recurrence risks • •
Anticipatory guidance
Early intervention services • • • • • • • • • • •
Reproductive options •‡ •‡ •‡ • •
Family support • • • • • • • • • • • • • •
Support groups • • • •
Long-term planning • • •§ •§
Sexuality • •
Medical evaluation
Growth o o o o o o o o o o o o o
Thyroid screening o¶ o o o o o o o
Hearing screening o S/o S/o S/o S/o S/o‡ S/o‡ S/o S/o S/o§ S/o
‡ ‡
Vision screening S/o S/o‡ S/o S/o S/o‡ S/o S/o‡ S/o S/o S/o S/o
Cervical spine roentgenogram o**
Echocardiogram • o
CBC o o
Psychosocial
Development and behavioral S/o S/o S/o S/o S/o S/o S/o S/o S/o S/o S/o S/o S/o S/o
School performance o o o o o
Socialization S S S
Downloaded from www.pediatrics.org by on August 12, 2006
* Assure compliance with the American Academy of Pediatrics “Recommendations for Preventive Pediatric Health Care.”
• to be performed; S subjective, by history; and o objective, by a standard testing method.
† Or at time of diagnosis.
‡ Discuss referral to specialist.
§ Give once in this age group.
¶ According to state law.
As needed.
** See discussion.
443 AMERICAN ACADEMY OF PEDIATRICS
4. 1. The prenatal laboratory or fetal imaging studies with expertise and experience in pediatric patients
leading to the diagnosis. and echocardiogram recommended).
2. The mechanism for occurrence of the disorder in • Duodenal atresia
the fetus and the potential recurrence rate for the • Constipation with increased risk of Hirschsprung
family. disease
3. The prognosis and manifestations, including the • Leukemia—more common in children with Down
wide range of variability seen in infants and chil- syndrome than in the general population, but still
dren with Down syndrome. rare ( 1%); leukemoid reactions, on the other
4. When applicable, additional studies that may re- hand, are relatively common as is polycythemia
fine the estimation of the prognosis (eg, fetal echo- (18%). Obtain complete blood count.
cardiogram, ultrasound examination for gastroin- • Congenital hypothyroidism (1% risk)
testinal malformations). • Respiratory tract infections
5. Currently available treatments and interventions.
This discussion needs to include the efficacy, po- Anticipatory Guidance
tential complications and adverse effects, costs, • Discuss increased susceptibility to respiratory
and other burdens associated with these treat- tract infection
ments. Discuss early intervention resources, par- • Discuss the availability and efficacy of early inter-
ent support programs, and any plausible future vention.
treatments. • Discuss the early intervention services in the com-
6. The options available to the family for manage- munity.
ment and rearing of the child using a nondirective • Inform the family of the availability of support
approach. In cases of early prenatal diagnosis, this and advice from the parents of other children with
may include discussion of pregnancy continua- Down syndrome.
tion or termination, rearing the child at home, • Supply names of Down syndrome support groups
foster care placement, and adoption. and current books and pamphlets (see “Bibliogra-
If the pregnancy is continued, a plan for delivery phy and Resources for New Parents”).
and neonatal care must be developed with the obste- • Discuss the strengths of the child and positive
trician and the family. Offer parent-to-parent con- family experiences.
tact. As the pregnancy progresses, additional studies • Check on individual resources for support, such as
may be valuable for modifying this management family, clergy, and friends.
plan (eg, detection of a complex heart defect by • Talk about how and what to tell other family
echocardiography). When appropriate, referral to a members and friends. Review methods of coping
clinical geneticist should be considered for a more with long-term disabilities.
extended discussion of clinical outcomes and vari- • Review the recurrence risk in subsequent preg-
ability, recurrence rates, future reproductive op- nancies and the availability of prenatal diagnosis.
tions, and evaluation of the risks for other family • Discuss unproven therapies.6 –12
members.
HEALTH SUPERVISION FROM 1 MONTH TO
1 YEAR: INFANCY
HEALTH SUPERVISION FROM BIRTH TO 1 Examination
MONTH: NEWBORNS
Physical Examination and Laboratory Studies
Examination
• Review the risk of serous otitis media (50%–70%).
Confirm the diagnosis of Down syndrome and If the tympanic membranes cannot be visualized,
review the karyotype with the parents. Review the or if the parents express any concern about their
phenotype. Discuss the specific findings with both child’s hearing, refer the infant to an otolaryngol-
parents whenever possible, and talk about the fol- ogist. Review the prior hearing evaluation (brain-
lowing potential clinical manifestations associated stem auditory evoked response and otoacoustic
with the syndrome. These may have to be reviewed emission and refer back to the otolaryngologist
again at a subsequent meeting. and audiologist if the initial evaluation was abnor-
mal for follow up examination and testing. A be-
Discuss and Review havioral audiogram should be obtained at 1 year
• Hypotonia in all children examined.
• Facial appearance • Check for strabismus, cataracts, and nystagmus by
6 months, if not done at birth. Check the infant’s
Evaluate for vision at each visit, using developmentally appro-
• Feeding problems priate subjective and objective criteria. By 6
• Strabismus, cataracts, and nystagmus at birth or months, refer the infant to a pediatric ophthalmol-
by 6 months ogist or an ophthalmologist with special expertise
• Congenital hearing loss with objective testing, and experience with infants with disabilities.
such as brainstem auditory evoked response or • Verify results of newborn thyroid function screen.
otoacoustic emission at birth or by 3 months5 Because of increased risk of acquired thyroid dis-
• Heart defects (approximately 50% risk). Perform ease, repeat at 6 and 12 months and then annual-
cardiac evaluation (consultation by a cardiologist ly.13,14
444 HEALTH SUPERVISION FOR CHILDREN WITH DOWN SYNDROME
Downloaded from www.pediatrics.org by on August 12, 2006
5. • Administer pneumococcal vaccine, as well as (see “Bibliography and Resources for New Par-
other vaccines recommended for all children un- ents”).
less there are specific contraindications. • Review the family’s understanding of the risk of
recurrence of Down syndrome and the availability
Anticipatory Guidance of prenatal diagnosis.
• Review the infant’s growth and development rel-
ative to other children with Down syndrome (Figs
HEALTH SUPERVISION FROM 1 TO 5 YEARS:
1– 4).15
EARLY CHILDHOOD
• Review availability of Down syndrome support
groups (see “Bibliography and Resources for New • Obtain a history and perform a physical examina-
Parents”). tion with attention to growth and developmental
• Assess the emotional status of parents and in- status.
trafamily relationships. Educate and support sib- • Review the risk of serous otitis media with hearing
lings and discuss sibling adjustments. At 6 to 12 loss. If the tympanic membranes cannot be com-
months, review the psychological support and in- pletely visualized (because of the frequent prob-
trafamily relationships, including long-term plan- lem of stenotic ear canals), check the child’s audio-
ning, financial planning, and guardianship. gram every 6 months up to 3 years or up to when
• Review the early intervention services relative to a pure tone audiogram is obtained. Refer the child
the strengths and needs of the infant and family to an otolaryngologist or audiologist if necessary
Fig 1. Percentiles for height and weight of
females with Down syndrome, 1 to 36
months of age. From Cronk C, Crocker AC,
Pueschel SM, et al. Growth charts for chil-
dren with Down syndrome: 1 month to 18
years of age. Pediatrics. 1988;81:102–110.
AMERICAN ACADEMY OF PEDIATRICS 445
Downloaded from www.pediatrics.org by on August 12, 2006
6. Fig 2. Percentiles for height and weight of
females with Down syndrome, 2 to 18 years
of age. From Cronk C, Crocker AC, Pueschel
SM, et al. Growth charts for children with
Down syndrome: 1 month to 18 years of age.
Pediatrics. 1988;81:102–110.
(approximately 50%–70% risk of serous otitis me- Anticipatory Guidance
dia between 3 and 5 years). • Review early intervention, including physical
• Check the child’s vision annually, using develop- therapy, occupational therapy, and speech, in the
mentally appropriate subjective and objective cri- preschool program and discuss future school
teria. Refer the child to a pediatric ophthalmolo- placement and performance.
gist or ophthalmologist with special expertise and • Discuss future pregnancy planning, risk of recur-
experience with children with disabilities every 2 rence of Down syndrome, and prenatal diagnosis.
years (approximately 50% risk of refractive errors • Assess the child’s behavior, and talk about behav-
between 3 and 5 years). ioral management, sibling adjustments, socializa-
• At 3 to 5 years, obtain radiographs for evidence of tion, and recreational skills.
atlantoaxial instability or subluxation. These may • Encourage families to establish optimal dietary
be obtained once during the preschool years. The and physical exercise patterns that will prevent
need for these studies has been questioned, but obesity.
they may be required for participation in the Special
Olympics. These studies are more important for chil- HEALTH SUPERVISION FROM 5 TO 13 YEARS:
dren who may participate in contact sports and are LATE CHILDHOOD
indicated in those who are symptomatic.16 –19 • Obtain a history and perform a physical examina-
• Perform thyroid screening tests annually. tion with attention to growth and developmental
• Discuss symptoms related to obstructive sleep ap- status.
nea, including snoring, restless sleep, and sleep • Obtain audiologic evaluation annually.
position. Refer to a specialist as indicated.20 • Obtain ophthalmologic evaluation annually.
446 HEALTH SUPERVISION FOR CHILDREN WITH DOWN SYNDROME
Downloaded from www.pediatrics.org by on August 12, 2006
7. Fig 3. Percentiles for height and weight
of males with Down syndrome, 1 to 36
months of age. From Cronk C, Crocker
AC, Pueschel SM, et al. Growth charts
for children with Down syndrome: 1
month to 18 years of age. Pediatrics.
1988;81:102–110.
• Perform thyroid screening tests annually (3%–5% • Discuss socialization, family status, and relation-
risk of hypothyroidism). ships, including financial arrangements and
• If appropriate, discuss skin problems: very dry guardianship.
skin and other skin problems are particularly com- • Discuss the development of age-appropriate social
mon in patients with Down syndrome. skills, self-help skills, and the development of a
• Discuss symptoms related to obstructive sleep sense of responsibility.
apnea, including snoring, restless sleep, and • Discuss psychosexual development, physical and
sleep position. Refer to a specialist as indi- sexual development, menstrual hygiene and man-
cated.20 agement, fertility, and contraception.21
• Discuss the need for gynecologic care in the pu-
Anticipatory Guidance bescent female. Talk about the recurrence risk of
• Review the child’s development and appropriate- Down syndrome with the patient and her family if
ness of school placement and developmental in- she were to become pregnant.22 Review the fact
tervention. that although there have been 2 case reports in
AMERICAN ACADEMY OF PEDIATRICS 447
Downloaded from www.pediatrics.org by on August 12, 2006
8. Fig 4. Percentiles for height and weight of
males with Down syndrome, 2 to 18 years of
age. From Cronk C, Crocker AC, Pueschel SM, et
al. Growth charts for children with Down syn-
drome: 1 month to 18 years of age. Pediatrics.
1988;81:102–110.
which a male has reproduced, males with Down • Discuss sexuality and socialization. Discuss the
syndrome are usually infertile.22 need for and degree of supervision and/or the
need for contraception. Make recommendations
HEALTH SUPERVISION FROM 13 TO 21 YEARS OR
for routine gynecologic care.
OLDER: ADOLESCENCE TO EARLY ADULTHOOD
• Discuss group homes and independent living op-
portunities, workshop settings, and other commu-
Examination nity-supported employment.
• Perform physical examination including CBC and • Discuss intrafamily relationships, financial plan-
thyroid function tests. ning, and guardianship.
• Obtain annual audiologic evaluation. • Facilitate transfer to adult medical care.
• Obtain annual ophthalmologic evaluation.
• Discuss skin care.
Committee on Genetics, 2000 –2001
Christopher Cunniff, MD, Chairperson
Anticipatory Guidance Jaime L. Frias, MD
• Discuss issues related to transition into adulthood. Celia Kaye, MD, PhD
• Discuss appropriateness of school placement with John B. Moeschler, MD
emphasis on adequate vocational training within Susan R. Panny, MD
the school curriculum.20,23 Tracy L. Trotter, MD
• Talk about the recurrence risk of Down syndrome Liaisons
with the patient and her family if she were to Felix de la Cruz, MD, MPH
become pregnant.22 National Institutes of Health
448 HEALTH SUPERVISION FOR CHILDREN WITH DOWN SYNDROME
Downloaded from www.pediatrics.org by on August 12, 2006
9. James W. Hanson, MD 11. Spigelblatt L, Laine-Ammara G, Pless IB, Guyver A. The use of alter-
American College of Medical native medicine by children. Pediatrics. 1994;94(6 pt 1):811– 814
12. American College of Medical Genetics. Statement on Nutritional Supple-
Genetics
ments and Piracetam for Children With Down Syndrome. Bethesda, MD:
Michele Lloyd-Puryear, MD, PhD American College of Medical Genetics; 1996
Health Resources and Services 13. Cutler AT, Benezra-Obeiter R, Brink SJ. Thyroid function in young
Administration children with Down syndrome. Am J Dis Child. 1986;140:479 – 483
Cynthia A. Moore, MD, PhD 14. Karlsson G, Gustafsson J, Hedov G, Ivarsson SA, Anneren G. Thyroid
Centers for Disease Control and dysfunction in Down’s syndrome: relation to age and thyroid autoim-
Prevention munity. Arch Dis Child. 1998;79:242–245
John Williams III, MD 15. Cronk C, Crocker AC, Pueschel SM, et al. Growth charts for children
American College of Obstetricians with Down syndrome: 1 month to 18 years of age. Pediatrics. 1988;81:
102–110
and Gynecologists
16. Davidson RG. Atlantoaxial instability in individuals with Down
Section Liaison syndrome: a fresh look at the evidence. Pediatrics. 1988;81:857– 865
H. Eugene Hoyme, MD 17. Msall ME, Reese ME, DiGaudio K, Griswold K, Granger CV, Cooke RE.
Section on Genetics Symptomatic atlantoaxial instability associated with medical and reha-
bilitative procedures in children with Down syndrome. Pediatrics. 1990;
Consultants 85(3 pt 2):447– 449
Marilyn J. Bull, MD 18. Pueschel SM, Findley TW, Furia J, Gallagher PL, Scola FH, Pezzullo JC.
William I. Cohen, MD Atlantoaxial instability in Down syndrome: roentgenographic, neuro-
Franklin Desposito, MD logic, and somatosensory evoked potential studies. J Pediatr. 1987;110:
515–521
Beth A. Pletcher, MD
19. Pueschel SM, Scola FH. Atlantoaxial instability in individuals with
Nancy Roizen, MD Down syndrome: epidemiologic, radiographic, and clinical studies. Pe-
Rebecca Wappner, MD diatrics. 1987;80:555–560
Staff 20. Pueschel SM, Pueschel JK, eds. Biomedical Concerns in Persons With Down
Syndrome. Baltimore, MD: Brookes Publishing; 1992
Lauri A. Hall
21. de la Cruz FF, LaVeck GD, eds. Human Sexuality and the Mentally
REFERENCES Retarded. New York, NY: Brunner/Mazel; 1973
22. Jagiello G. Reproduction in Down syndrome. In: de la Cruz FF, Gerald
1. American Academy of Pediatrics Committee on Genetics. Health su-
PS, eds. Trisomy 21 (Down Syndrome): Research Perspectives. Baltimore,
pervision for children with Down syndrome. Pediatrics. 1994;93:855– 859
MD: University Park Press; 1981;151–162
2. Cohen WI. Health care guidelines for individuals with Down syndrome
23. Fenner ME, Hewitt KE, Torpy DM. Down’s syndrome: intellectual
(Down syndrome preventive medical checklist). Down Syndrome Q.
behavioural functioning during adulthood. J Ment Defic Res. 1987;31(pt
1996;1:1–10
3):241–249
3. Cooley WC, Graham JM Jr. Down syndrome: an update and review for
the primary pediatrician. Clin Pediatr (Phila). 1991;30:233–253
4. de la Cruz F. Medical management of mongolism or Down syndrome. BIBLIOGRAPHY AND RESOURCES FOR NEW
In: Mittler P, de Jong JM, eds. Biomedical Aspects. Research to Practice in PARENTS
Mental Retardation: Fourth Congress of the International Association for the
Scientific Study of Mental Deficiency. Vol 3. Baltimore, MD: University Bibliography
Park Press; 1977;221–228 Cairo S, Cairo J, Cairo T. Our Brother Has Down’s Syndrome: An Introduction
5. Dahle AJ, McCollister FP. Hearing and otologic disorders in children for Children. Toronto, Ontario: Annick Press Ltd; 1985
with Down syndrome. Am J Ment Defic. 1986;90:636 – 642 Hanson MJ. Teaching the Infant With Down Syndrome: A Guide for Parents and
6. National Down Syndrome Congress. Position Statement on Sicca Cell Professionals. 2nd ed. Austin, TX: Pro-Ed; 1987
Therapy. Atlanta, GA: National Down Syndrome Congress; 1989 Pueschel SM. A parent’s guide to Down syndrome. Baltimore, MD: Brookes
7. Nickel RE. Controversial therapies for young children with develop- Publishing; 1990
mental disabilities. Infants Young Child. 1996;8:29 – 40 Stray-Gunderson K. Babies With Down Syndrome: A New Parents Guide.
8. National Down Syndrome Society. Position Statement on Vitamin Related Kensington, MD: Woodbine House; 1986 (English and Spanish editions)
Therapies. New York, NY: National Down Syndrome Society; 1997.
Available at: http://www.ndss.org. Accessed June 1998
9. National Down Syndrome Society. Position Statement on Use of Piracetam. Resources
New York, NY: National Down Syndrome Society; 1996. Available at: March of Dimes, Birth Defects Foundation, 1275 Mamaroneck Ave, White
http://www.ndss.org. Accessed June 1998 Plains, NY 10605; Telephone: 914/428 –7100
10. National Down Syndrome Congress. National intervention in children National Down Syndrome Congress, 1605 Chantilly Dr, Suite 250, Atlanta,
with Down syndrome. Atlanta, GA: National Down Syndrome Congress; GA 30324; Telephone: 404/633–1555 or 800/232– 6372
1999. Available at: http://www.ndsccenter.org. Accessed November National Down Syndrome Society, 666 Broadway, New York, NY 10012;
1999 Telephone: 212/460 –9330 or 800/221– 4602
11.
AMERICAN ACADEMY OF PEDIATRICS 449
Downloaded from www.pediatrics.org by on August 12, 2006
10. Health Supervision for Children With Down Syndrome
Committee on Genetics
Pediatrics 2001;107;442-449
DOI: 10.1542/peds.107.2.442
This information is current as of August 12, 2006
Updated Information including high-resolution figures, can be found at:
& Services http://www.pediatrics.org/cgi/content/full/107/2/442
References This article cites 10 articles, 2 of which you can access for free
at:
http://www.pediatrics.org/cgi/content/full/107/2/442#BIBL
Citations This article has been cited by 7 HighWire-hosted articles:
http://www.pediatrics.org/cgi/content/full/107/2/442#otherarticle
s
Subspecialty Collections This article, along with others on similar topics, appears in the
following collection(s):
Genetics & Dysmorphology
http://www.pediatrics.org/cgi/collection/genetics_and_dysmorph
ology
Permissions & Licensing Information about reproducing this article in parts (figures,
tables) or in its entirety can be found online at:
http://www.pediatrics.org/misc/Permissions.shtml
Reprints Information about ordering reprints can be found online:
http://www.pediatrics.org/misc/reprints.shtml
Downloaded from www.pediatrics.org by on August 12, 2006